Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: A 4 year follow-up study

Artificial Organs

Volumn 21, Issue 5, 1997, Pages 364-368

  Fadul, Jamal E M ^a   Vessby, Bengt ^a   Wikström, Björn ^a   Danielson, Bo G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

familial homozygous; hypercholesterolemia; lipoprotein (a); low density lipoprotein apheresis

Indexed keywords

CHOLESTEROL; DISEASES; HEART; LIPOPROTEINS; PATIENT TREATMENT;

FAMILIAL HOMOZYGOUS; FAMILIAL HYPERCHOLESTEROLEMIA; FOLLOW-UP STUDIES; HYPERCHOLESTEROLEMIA; LIPOPROTEIN (A); LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN APHERESIS; LOW DENSITY LIPOPROTEINS; MYOCARDIAL INFARCTION; PRE-TREATMENTS;

CARDIOLOGY;

LOW DENSITY LIPOPROTEIN;

ADULT; APHERESIS; ARTICLE; CASE REPORT; FAMILIAL DISEASE; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL;

EID: 0030916902     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00732.x     Document Type: Article

References (20)

1. Russell DW, Esser V, Hobbs HH. Molecular basis of familial hypercholesterolemia. Arteriosclerosis 1989;9:18-13.
2. Brown MS, Goldstein JL. Familial hypercholesterolemia. A genetic defect in the LDL-receptor. N Engl J Med 1976;294: 1386-90.
3. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary heart disease. The PROCAM experience. Am J Cardiol 1992;70:733-7.
4. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L, Bondjers G. Apolipoprotein (a) and ischaemic heart disease in familial hypercholesterolemia. Lancet 1990; 335:1360-3.
5. Scanu AM, Lawn RM, Berg K. Lipoprotein (a) and atherosclerosis. Ann Intern Med 1991;115:209-18.
6. Kane JP, Havel RJ. Treatment of hypercholesterolemia. Annu Rev Med 1986;37:427-35.
7. Gordon BR, Stein E, Johnes P, Illingworth DR. Indication for low-density lipoprotein apheresis. Am J Cardiol 1994;74: 1109-12.
8. Gordon BR, Kelsey SF, Bilheimer DW. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 1992;70:1010-6.
9. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study. Atherosclerosis 1992;95:1-13.
10. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987;68:19-25.
11. Havel RJ, Eder HA, Bragdon JH. The determination and chemical composition of ultracentrifugally separated lipoprotein in human serum. J Clin Invest 1955;34:1345-53.
12. Seigler L, Wu WT. Separation of serum high-density lipoprotein for cholesterol determination: Ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 1981;27:838-41.
13. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkl E, Utermann G. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholeslerolemia. N Engl J Med 1990;322:1494-9.
14. Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LD, Mann JI, Swan AV. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in St. Thomas Atherosclerosis Regression Study (STARS). Lancet 1992;339: 563-9.
15. Kane JP, Malloy MJ, Ports TA, Phillips NP, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
16. Cashin-Hemphill L, Mack WJ, Pogoda JM. Beneficial effects of colstipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA 1990;264:3013-7.
17. Brown G, Albers JJ, Fisher LD. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323:1289-98.
18. Bambauer R, Schiel R, Keller HE, Klinkmann J, Latza R. Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein (a) levels Artif Organ 1996;20:340-3.
19. Koizumi J, Koizumi I, Uno Y, Inazu A, Kajinami K, Haraki T, Yagi K, Kamon N, Miyamoto S, Takegoshi T, Mabuchi H, Takeda R, Tani N, Takada S. Reduction of lipoprotein (a) by LDL apheresis using dextran sulfate cellulose column in patients with familial hypercholesterolaemia. Atherosclerosis 1993;100:65-74.
20. Lasuncion MA, Teruel JL, Alvaerz JJ, Carrero P, Ortuno J, Gomez-Coronado D. Changes in lipoprotein (a), LDL cholesterol and apolipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL apheresis. Eur J Clin Invest 1993;23:819-26.